Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1030 of 1,261

  1. US 7553936

    Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  2. US 7553852

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  3. US 7553840

    4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  4. US 7553971

    Aryl aniline β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  5. US 7553931

    Complement depletion using recombinant human C3-derivatives

    PLS-Design GmbH · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  6. US 7553484

    Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) molecule

    The Regents of the University of California · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  7. US 7554021

    Composition and method for self-assembly and mineralization of peptide amphiphiles

    Northwestern University · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  8. US 7553867

    Furan or thiophene derivative and medicinal use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  9. US 7553855

    Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  10. US 7553935

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  11. US 7553934

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  12. US 7553653

    Variants and chemically-modified variants of phenylalanine ammonia-lyase

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  13. US 7553490

    Vaccines against Escherichia coli O157 infection

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  14. US 7550617

    Compositions and methods for the treatment of renal and cardiovascular disease

    The Board of Regents of the University of Texas System · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  15. US 7550459

    Tetrahydroquinoline analogues as muscarinic agonists

    ACADIA Pharmaceuticals Inc. · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  16. US 7550587

    Photosensitizer and method for production thereof

    Obschestvo S Ogranichennoi Otvetstvennostiju “Rada-Pharma” · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  17. US 7550584

    Methods of purifying beta glucans

    Immudyne, Inc. · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  18. US 7550595

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  19. US 7550503

    Physiologically active substances

    American Regent, Inc. · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  20. US 7550460

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  21. US 7550454

    Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

    ACADIA Pharmaceuticals Inc. · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  22. US 7550275

    Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide

    United States of America as represented by the Secretary of the Air Force · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  23. US 7550141

    Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  24. US 7550005

    Coated implantable medical device

    Cook Regentec LLC · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.